Tolerance Clinical Trials in New York, New York
3 recruitingNew York, New York
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.
Platinum Resistant Ovarian CancerPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
TILT Biotherapeutics Ltd.29 enrolled3 locationsNCT05271318
Recruiting
Rare and Atypical Diabetes Network
Diabetes MellitusMetabolic DiseaseEndocrine System Diseases+4 more
University of South Florida2,000 enrolled13 locationsNCT05544266
Recruiting
Phase 2Phase 3
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Pregnancy ComplicationsGlucose Metabolism DisordersDiabetes, Gestational+1 more
Jaeb Center for Health Research30 enrolled5 locationsNCT06535789